Furthermore, suppressed p62 expression increased the deacetylase activity of HDAC6 in HCC cells, suggesting that sorafenib-induced autophagy may upregulate HDAC6 activity by degrading p62. Here, HDAC6 is linked to hepatocellular carcinoma.